InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Immunome Inc.

IMNM Clue Score30
United States Fiscal year ends December CIK 0001472012 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Jack Higgins
11 Sep 2026
Chief Scientific Officer
Sold after exercise
13,200
$25.32
$334.22K
Kinney Horn
4 Aug 2026
Chief Business Officer
Sold after exercise
90,616
$25.09
$2.27M
Kinney Horn
7 Jul 2026
Chief Business Officer
Sold after exercise
1,092
$25.00
$27.30K
Robert Lechleider
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,072
$23.44
$376.73K
Robert Lechleider
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,214
$22.76
$369.03K
Robert Lechleider
2 Jul 2026
Chief Medical Officer
Sold after exercise
22,714
$21.95
$498.57K
Robert Lechleider
25 Jun 2026
Chief Medical Officer
Sold after exercise
14,420
$20.66
$297.92K
Robert Lechleider
25 Jun 2026
Chief Medical Officer
Sold after exercise
40,580
$19.56
$793.74K
Max Rosett
15 Jun 2026
Chief Financial Officer
Sold after exercise
60,000
$18.23
$1.09M
Max Rosett
2 Apr 2026
Chief Financial Officer
Sold after exercise
1,344
$22.48
$30.21K
Max Rosett
2 Apr 2026
Chief Financial Officer
Sold after exercise
63,656
$21.91
$1.39M
Show all 39 transactions →

What was left out

Form 4 filings counted 37
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 11
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 999,610
History held since 5 Oct 2020